Laura McAdam

ORCID: 0000-0002-4650-7232
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Muscle Physiology and Disorders
  • Neurogenetic and Muscular Disorders Research
  • Cerebral Palsy and Movement Disorders
  • Children's Physical and Motor Development
  • Cardiomyopathy and Myosin Studies
  • Respiratory Support and Mechanisms
  • Family and Disability Support Research
  • Adolescent and Pediatric Healthcare
  • Child Nutrition and Feeding Issues
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • RNA modifications and cancer
  • Neuroscience and Neuropharmacology Research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Congenital Anomalies and Fetal Surgery
  • Bone fractures and treatments
  • Neonatal Respiratory Health Research
  • Cardiovascular Effects of Exercise
  • Eating Disorders and Behaviors
  • Exercise and Physiological Responses
  • Vitamin D Research Studies
  • Anesthesia and Neurotoxicity Research
  • Muscle activation and electromyography studies
  • Traumatic Brain Injury Research
  • Autism Spectrum Disorder Research
  • Trauma and Emergency Care Studies

Holland Bloorview Kids Rehabilitation Hospital
2015-2024

University of Toronto
2015-2024

Hospital for Sick Children
2012-2020

SickKids Foundation
2016-2020

Children's National
2015-2018

George Washington University
2015-2018

University of California Davis Medical Center
2015-2016

University of Padua
2016

University Hospital Cologne
2016

University of Cologne
2016

Duchenne muscular dystrophy is a progressive neuromuscular condition that has high rate of cognitive and learning disabilities as well neurobehavioral disorders, some which have been associated with disruption dystrophin isoforms. Retrospective cohort 59 boys investigated the profile dystrophy. Full-scale IQ < 70 was seen in 27%; disability 44%, intellectual 19%; attention-deficit/hyperactivity disorder 32%; autism spectrum disorders 15%; anxiety 27%. Mutations affecting Dp260 isoform...

10.1177/0883073815570154 article EN Journal of Child Neurology 2015-02-06

We aimed to perform an observational study of age at loss independent ambulation (LoA) and side-effect profiles associated with different glucocorticoid corticosteroid (GC) regimens in Duchenne muscular dystrophy (DMD).We studied 340 participants the Cooperative International Neuromuscular Research Group Natural History Study (CINRG-DNHS). LoA was defined as continuous wheelchair use. Effects prednisone or prednisolone (PRED)/deflazacort (DFZ), administration frequency, dose were analyzed by...

10.1212/wnl.0000000000001950 article EN Neurology 2015-08-27

<h3>Objective:</h3> To correlate time to loss of ambulation (LoA) and different truncating <i>DMD</i> gene mutations in a large, prospective natural history study Duchenne muscular dystrophy (DMD), with particular attention amenable emerging molecular treatments. <h3>Methods:</h3> We analyzed data from the Cooperative International Neuromuscular Research Group Natural History Study for participants single- or multi-exon deletions duplications defined exon boundaries (n = 186), small...

10.1212/wnl.0000000000002891 article EN Neurology 2016-07-26

Background: Duchenne muscular dystrophy, a progressive muscle disorder that occurs in males, causes gradual decline strength. This is associated with the development of scoliosis. Previous studies have shown use glucocorticoids slows progression scoliosis, but it unknown if spine remains straight long term. We examined glucocorticoid treatment has long-term effect on prevalence Methods: Fifty-four boys who had been diagnosed dystrophy while they were still walking enrolled non-randomized...

10.2106/jbjs.l.01577 article EN Journal of Bone and Joint Surgery 2013-06-01

We describe changes in pulmonary function measures across time Duchenne muscular dystrophy patients treated with glucocorticoids (GCs) > 1 year compared to GC naïve the Cooperative International Research Group Natural History Study, a multicenter prospective cohort study. 397 participants underwent 2799 assessments over period up 10 years. Fifty-three (< month exposure) were 322 subjects cumulative treatment. Forced vital capacity (FVC), peak expiratory flow rate (PEFr), maximal inspiratory...

10.1016/j.nmd.2018.07.004 article EN cc-by-nc-nd Neuromuscular Disorders 2018-08-29

10.1016/j.ajhg.2016.08.023 article EN publisher-specific-oa The American Journal of Human Genetics 2016-10-16

Abstract Duchenne muscular dystrophy (DMD) is characterized by muscle degeneration and progressive weakness. There considerable inter-patient variability in disease onset progression, which can confound the results of clinical trials. Here we show that a common null polymorphism (R577X) ACTN3 significantly reduced strength longer 10 m walk test time young, ambulant patients with DMD; both are primary outcome measures We have developed double knockout mouse model, also shows strength, but...

10.1038/ncomms14143 article EN cc-by Nature Communications 2017-01-31

Purpose: To evaluate the feasibility and acceptability of a coaching intervention (Solution-Focused Coaching in pediatric rehabilitation [SFC-Peds]) related to physical activity diet males with Duchenne muscular dystrophy. Methods: A pre-post design was employed. Participants had five sessions over 8 weeks. The first session face-to-face, followed by four virtual sessions. Feasibility criteria included recruitment rates, attrition, fidelity. Canadian Occupational Performance Measure (COPM)...

10.1080/17518423.2017.1289271 article EN Developmental Neurorehabilitation 2017-03-08

Impaired cough results in airway secretion retention, atelectasis and pneumonia individuals with Duchenne muscular dystrophy (DMD). Lung volume recruitment (LVR) stacks breaths to inflate the lungs greater volumes than spontaneous effort. LVR is recommended DMD clinical care guidelines but not well studied. We aimed determine whether twice-daily LVR, compared standard of alone, attenuates decline FVC at 2 years boys DMD.

10.1136/thoraxjnl-2021-218196 article EN cc-by-nc Thorax 2022-03-02

Abstract Background Most research into clinical care of Duchenne or Becker dystrophinopathies (MD) has focused on slowing progressive muscular weakness and extending lifespan. Scarce attention been paid to the “human” aspects such as psychosocial health, living a fulfilling life, dealing with disability stigma. This study partnered clinicians identify address local systemic barriers these human care. Methods We employed participatory qualitative design at multidisciplinary MD clinic using 2...

10.1111/cch.12526 article EN Child Care Health and Development 2017-11-08

We report the recruitment activities and outcomes of a multi-disease neuromuscular patient registry in Canada. The Canadian Neuromuscular Disease Registry (CNDR) registers individuals across Canada with confirmed diagnosis disease. Diagnosis contact information are collected all diseases detailed prospective data is for 5 specific diseases: Amyotrophic Lateral Sclerosis (ALS), Duchenne Muscular Dystrophy (DMD), Myotonic (DM), Limb Girdle (LGMD), Spinal Atrophy (SMA). Since 2010, CNDR has...

10.3233/jnd-200538 article EN other-oa Journal of Neuromuscular Diseases 2020-09-08
Coming Soon ...